Related Experiment Video
Updated: Apr 29, 2026

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
Published on: September 14, 2009
In-stent ulceration: an unusual pathology
Jagadeesh Kumar Kalavakunta1, Shravan Gangula2, Vishal Gupta2
1Department of Cardiology, Michigan State University, East Lansing, MI 48824, USA.
A rare case of carotid artery in-stent restenosis caused by an ulcerated plaque led to neurological symptoms. This report details the unusual mechanism and reviews current treatment options for in-stent restenosis.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Interventional Cardiology
Background:
- In-stent restenosis (ISR) is a common complication following interventional therapy, occurring in 10-60% of cases.
- While various mechanisms contribute to ISR, restenosis specifically caused by an ulcerated plaque is exceptionally rare and poorly documented.
- Ulcerated plaques can pose unique challenges in restenosis management.
Purpose of the Study:
- To report a rare case of neurological symptoms secondary to carotid artery in-stent restenosis caused by an ulcerated plaque.
- To elucidate the specific mechanisms involved in this unusual presentation of ISR.
- To discuss the available treatment strategies for complex in-stent restenosis.
Main Methods:
- Case report of a 72-year-old male presenting with neurological deficits.
- Review of diagnostic imaging and interventional procedures.
- Literature review on mechanisms and management of in-stent restenosis, particularly ulcerated plaque-related cases.
Main Results:
- The patient presented with neurological symptoms attributed to severe in-stent restenosis of the carotid artery.
- Diagnostic findings confirmed an ulcerated plaque as the cause of restenosis.
- The case highlights a rare but significant etiology for ISR.
Conclusions:
- In-stent restenosis due to an ulcerated plaque is a rare but critical cause of neurological events.
- Understanding the specific mechanisms is crucial for effective diagnosis and treatment.
- This case underscores the importance of considering diverse etiologies in managing ISR and its complications.
Related Concept Videos
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...

